Anticancer agent 9

• Description:

  Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H311-H314-H318-H401-H411

• Target:

  Amino Acid Derivatives

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-9.html

• Purity:

  96.58

• Solubility:

  DMSO : 50 mg/mL (ultrasonic)

• Smiles:

  O=C(OC)CNC1=CC(CS(=O)(/C=C/C2=C(OC)C=C(OC)C=C2OC)=O)=CC=C1OC

• Molecular Formula:

  C22H27NO8S

• Molecular Weight:

  465.52

• Precautions:

  P260-P264-P270-P273-P280-P301+P330+P331-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P330-P361+P364-P363-P391-P405-P501

• References & Citations:

  [1]Pallela VR, et, al. Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z) -isomers of ON 01910•Na (Rigosertib®), a phase III clinical stage anti-cancer agent. Org Biomol Chem. 2013 Mar 28;11 (12) :1964-77.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [592542-61-5]